Lewy Body Dementia
Dementia with Lewy Bodies: Clinical Diagnosis and Therapeutic ApproachGold G.
Geneva University School of Medicine and Geneva University Hospitals, Geneva, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Dementia with Lewy bodies is one of the most common dementias in the elderly after Alzheimer’sdisease. It can be recognized on the basis of several clinical characteristics including progressivedementia with marked slowing and fluctuations, persistent visual hallucinations and an extrapyramidalsyndrome. Several other clinical and imaging features are highly suggestive such as the presenceof rapid eye movement sleep disorder, severe sensitivity to neuroleptics and specificneuroimaging abnormalities. Therapeutic strategies include prescription of L-dopa and cholinesteraseinhibitors such as rivastigmine, and avoidance of anticholinergic medications and neuroleptics.Physicians who care for older people should have a heightened awareness of this entity in orderto diagnose it early, avoid mistaking it for delirium and initiate appropriate treatment.
© 2009 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.